Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly.See plans and pricing.See plans →
Nexalin Technology Secures Funding Through Direct Offering
PUBLIC · NXLAug 19, 2026•2 days ago
Amount Raised
$750,000
Round Type
Post-IPO Equity
HoustonBiotechnologyHealth Care
Investors
Institutional Investor
Description
On August 19, 2026, Nexalin Technology, Inc. entered into a securities purchase agreement with a single institutional investor. The company will issue 2,419,355 shares of its common stock at an offering price of $0.31 per share. In addition, the company will sell common stock warrants allowing for the purchase of up to 1,209,677 shares.
Company Information
Company
Nexalin Technology
Location
Houston, Texas, United States
About
Nexalin designs and develops innovative neurostimulation products to uniquely help combat the ongoing global mental health epidemic. All of Nexalin's products are believed to be non-invasive and undetectable to the human body and are developed to provide relief to those afflicted with mental health issues. Nexalin utilizes bioelectronic medical technology to treat mental health issues. Nexalin believes its neurostimulation medical devices can penetrate structures deep in the mid-brain that are associated with mental health disorders.
Don't miss Nexalin Technology's next move
Get an email the moment Nexalin Technology raises, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
Related People
Suggested for you
2 contacts
Predictive Intelligence
Strategic
ML-powered predictions for Nexalin Technology's next move
HoustonBiotechnologyHealth Care